This illustrated review article gives an evidence-based update on the different modalities used for imaging peripheral vascular disease (duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and digital subtraction angiography). After discussing the latest technological developments for each modality, their limitations are also highlighted. The evidence is presented for the various modalities' roles in the imaging of peripheral vascular disease, including problem-solving applications. The strengths and weaknesses of each modality are therefore critically appraised, including the salient technological, clinical, and fi nancial aspects. This review allows the general and specialist practitioner to make an informed decision on how best to deploy imaging tests in peripheral vascular disease as part of an evidence-based approach. The article concludes with a rational imaging algorithm for the investigation of peripheral vascular disease.
Introduction
Peripheral vascular disease affects 27 million people in Europe and North America, with the majority asymptomatic or undiagnosed. The Joint American College of Cardiology and American Heart Association Guidelines 1 provide extensive evidence-based recommendations for the diagnosis, investigation and management of peripheral vascular disease. The current role of imaging in peripheral vascular disease is summarized in Table 1 .
The current state of imaging technology for peripheral vascular disease is discussed below under each modality: duplex ultrasound (DU); digital subtraction angiography (DSA); magnetic resonance angiography (MRA); and computed tomography angiography (CTA). As important as it is to understand the new solutions provided by advances in technology, it is also important to understand the residual limitations for each imaging modality.
Duplex ultrasound
Duplex systems have curvilinear (2) (3) (4) (5) and rectilinear (7) (8) (9) (10) (11) (12) MHz) probes for aortoiliac and for femoropopliteal imaging, respectively. Real-time B-mode imaging in combination with color Doppler and pulsed-wave Doppler waveform sampling provide both anatomical and hemodynamic (functional) information. DU is widely available, inexpensive, mobile, noninvasive, nonionizing, and does not require nephrotoxic contrast.
Duplex ultrasound has been tested (against DSA as gold-standard) in patients with peripheral vascular disease and found to have good agreement for detecting signifi cant stenoses and occlusions (sensitivity 70%, specifi city 98%, positive predictive value 0.82, negative predictive value 0.95, and κ-value of 0.72). When the arterial tree was further sub-classifi ed into pelvic, thigh, and calf regions, DU was found to have a high negative predictive value (0.99) for the pelvic region -potentially ideal as a secondary sign for confi rming aortic disease. 2 DU also has an overall accuracy of 88% in the surveillance of lower limb venous bypass grafts. 3 
Limitations of duplex ultrasound
Ultrasound has several operator-dependent and operatorindependent limitations. Ultrasound is a focal imaging tool, and cannot defi ne co-existent extrinsic pathology completely or provide global imaging of the cardiovascular system. Ultrasound cannot provide reliable imaging if there are poor acoustic windows (eg, bowel gas attenuation, diffuse vascular calcifi cation, or metallic stents) or poor intrinsic echogenicity of the tissues. Duplex scanning is time-consuming and inconvenient post-operatively -when the region of interest is obscured by dressings -and removing these can involve infection risk. A lack of vascular ultrasound expertise limits the use of DU for referral during working hours.
The sensitivity of DU was found to vary widely (from 46% to 88%) for detecting signifi cant arterial stenoses, depending on which arterial segment was being examined. 4 DU failed to visualize up to 10% of aortoiliac, 2% of femoropopliteal, and 13% of tibioperoneal arterial segments. The sensitivity of DU is as low as 72% in the pelvic region for detecting signifi cant obstructions. 5 In addition, some authors claim DU is not reliable for clinical decisions based on visualization of run-off vessels, 2 or for evaluating residual stenosis after peripheral angioplasty. 6 Figure 1 shows an example of DU imaging.
Digital subtraction angiography
Digital subtraction angiography provides the gold-standard for imaging in peripheral vascular disease, especially prior to surgical intervention. 7 Digital cine-fl ouroscopy allows real-time guidance of interventional procedures which are fi rst-line management for critical ischemia, especially in patients who are not fi t for a general anesthetic.
Modern angiography suites consist of ultra-rapid digital cine-fl uoroscopy systems, mounted on C-arms, with digital display facilities and complex post-processing software. The most critical step is the computerized subtraction of the precontrast (mask) image from the post-contrast image, producing a resultant image of contrast-fi lled vessels only. Digital subtraction techniques reduce the dose of contrast required. Good spatial and temporal resolution, combined with a large fi eld of view, allows bolus chasing from the aorta to the feet. The peripheral arterial tree can be seen and mapped quickly with overlapping runs. Large numbers of collaterals can be anatomically visualized quickly and in one session (compared to the challenge of mapping collaterals accurately with DU).
More recently, rotational computed angiography (Dyna-CT) has been introduced. This involves a modifi ed angiography image intensifi er, with a rotating C-arm, so that computed tomography-like slices can be acquired in the interventional suite.
Limitations of digital subtraction angiography
Disadvantages of DSA include the necessity of arterial access. Arterial puncture is a relative burden (if the same diagnosis could be made without it), especially if the patient does not benefi t from an endovascular intervention at the same time. DSA involves ionizing radiation (for both patients and staff) and nephrotoxic contrast. The mask projections are easily distorted by patient movement, although modern software systems compensate for some motion artefacts. Slow fl ow can be missed depending on technical parameters (contrast injection rate, projection, or frame rate). 
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Finally, DSA is a form of luminal imaging, with information about extrinsic pathology deducible only indirectly (or not at all). Eccentric or en face plaque can be missed, 7 and there is some inter-observer variation in grading stenoses. The latter can be reduced by using the quantitative tools in modern vascular software packages. Figure 2 shows an example of DSA images.
Magnetic resonance angiography
Magnetic resonance angiography consists of moving-table bolus-chase protocols using gadolinium-enhancement in combination with a phased-array leg angiography coil. Most tertiary vascular centers now have access to a dedicated magnetic resonance service, with fewer peripheral centers able to offer diagnostic expertise in this fi eld. A three-step protocol with contrast enhancement is reputed to have higher diagnostic accuracy than two-dimensional (2D) time of fl ight MRA. 9, 10 Magnetic resonance angiography is ideal for problemsolving imaging of the below-knee run-off, which is not easily assessed by DU or DSA (problem-solving refers to the imaging in cases where the fi rst-line modality cannot provide the diagnostic answers). Parallel imaging and innovative κ-space re-ordering have allowed sub-millimeter isotropic voxel acquisition in the distal run-off stations. "Hybrid" MRA is the combination of a time resolved MRA of the calf and foot followed by a bolus-chase multistation MRA. Time resolved imaging can be 2D or 3D. Hybrid MRA can detect run-off arteries not seen by DSA, which is of supreme importance in planning limb salvage surgery. 11 Magnetic resonance angiography can provide a global assessment of the vascular system with relative ease. Additional unsuspected lesions (stenoses, aneurysms, or dissections) have been found in up to 20% of peripheral vascular patients. Vessel-wall specifi c sequences (eg, fatsaturated T1 gradient-echo, contrast-enhanced inversion recovery gradient echo) can be used to delineate some of these additional lesions with little increase in scan time. In addition, dark-blood HASTE (half-fourier acquisition single-shot turbo spin-echo) imaging is used for the aortic wall, however this technique has not been widely used or accepted for peripheral arterial imaging. 12 Unlike DU, MRA allows simultaneous angiographic as well as anatomical volume acquisition of the whole body in seconds whilst maintaining high spatial resolution. This allows both luminal and extra-luminal pathology to be shown simultaneously, although magnetic resonance imaging is poorer for bony anatomy than computed tomography.
Figure 1
Proximal superfi cial femoral artery stenosis. Color fl ow ultrasound imaging of a diseased superfi cial femoral artery. Conventionally, red fl ow is towards the transducer and blue fl ow is away from the transducer. In this case, because of the position of the transducer, red is also fl ow towards the periphery, and blue is reverse fl ow. A short region of narrowing (marked with white arrow) generates a high velocity jet at the narrowest point and immediately downstream (towards right of arrow). The poststenotic fl ow is characterized by irregular, scintillating color changes from red through blue, the effect being primarily due to to aliasing, an artefact arising from blood velocities which exceed the maximum velocity scale setting, but also from turbulence. Similarly, near both walls of the artery, disturbed blood fl ow manifests as a mixture of forward (red) and reverse (blue) fl ow. These color changes are more regular and continue for a short distance downstream as the jet slows, becoming unstable in the process. It has been claimed that MRA has a higher sensitivity than DU in detecting signifi cant stenosis in any arterial segment (pelvic, femoral, or calf). 2 In a prospective trial with 295 patients, using catheter angiography as a gold-standard, it was found that MRA was more sensitive (84% vs 76%) and more specifi c (97% vs 93% ) than DU. In particular, MRA was found to be superior in the aorto-iliac segment, where bowel gas confounds ultrasound techniques. 13 A) B) 
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Contrast enhancement not only improves the signal-to-noise ratio but also reduces imaging time. Contrast-enhanced MRA is similar or superior in accuracy to DU for the assessment of patency in lower limb bypass grafts. 14 If it were possible to use MRA instead of DU in every case -which it is not, as many patients have contra-indications or sub-optimal magnetic imaging -it has been claimed that this would reduce the requirement for additional vascular imaging procedures by up to 42%. 15 Invasive (intra-arterial contrast-enhanced) MRA has been studied by several groups. Intra-arterial enhancement required only 5% of the conventional gadolinium dose. 16 When comparing invasive MRA with conventional DSA, there was a sensitivity of 93% and specifi city of 86% for signifi cant stenoses. The overall accuracy of the invasive method was lowest for the infrapopliteal segment (86%) and highest (93%) for the femoropopliteal region. 17 
Limitations of magnetic resonance angiography
Like DSA, contrast enhanced magnetic resonance imaging is sensitive to patient motion artefacts. If there is patient motion between the mask acquisition and postcontrast acquisition, there will be image degradation following subtraction. However, evaluation of the nonsubtracted source images is always part of the image interpretation and unlike DSA, purely unenhanced MRA is also possible.
The relative high cost and limited availability of services (especially after working hours) restricts the clinical utility of MRA. MRA involves strong magnetic fi elds, creating many contraindications (eg, pacemakers).
Long scan times (in a narrow tunnel) are problematic for claustrophobic patients, and sedation is sometimes necessary. Magnetic resonance cannot image calcifi cation or steel stents; although the former can be an advantage in some circumstances, the latter causes susceptibility artefacts easily recognizable as signal voids in the image. Metallic structures within the vessel lumen or adjacent to the vessel may cause magnetic susceptibility artefacts that obscure the vessel lumen leading to a false diagnosis of a stenosis or obstruction.
The most serious limitation of MRA is venous contamination. The application of a compression cuff to the thigh (infl ated to pressures of up to 50 mmHg) can reduce venous contamination. 18 Some groups have reported a reduction in venous contamination with "hybrid" protocols using time resolved imaging. In addition, several 3D time-resolved protocols, including "TRICKS" (time-resolved imaging of contrast kinetics), "TREAT" (time-resolved echo-shared angiographic technique), and "TWIST" (time-resolved angiography with interleaved stochastic trajectories) have been shown to minimize venous contamination in the calf and pedal vessels. [19] [20] [21] With all these techniques, temporal resolution is improved at the cost of reduced spatial resolution, and research is now focusing on how to improve on this tradeoff. 21 Despite improved protocols, technically poor magnetic resonance studies occur in 13.7% of all patients. 22 Up to 33% of clinicians will still request DSA after MRA in order to make a therapeutic decision. 23 In addition, MRA overestimates stenoses in up to 7% of cases when compared to DSA as the gold-standard. 24 However DSA itself may underestimate true lesion grade if used as gold-standard as has previously been implied from direct intra-arterial pressure measurements. 5 High-fi eld (3.0 Tesla) imaging is also being investigated for clinical applications, and improvements in the technology may well resolve some of these current limitations.
The use of gadolinium-based contrast agents has recently been associated with nephrogenic systemic fi brosis in patients with renal impairment (all cases have been in patients with a glomerular fi ltration rate of less than 60 ml/min). The European Society of Urogenital Radiology (see http://www. esur.org) and the American College of Radiology Blue Ribbon Panel on Magnetic Resonance Safety (see http://www.acr. org) have both issued detailed guidance on this issue.
The concerns arising from gadolinium-based contrast agents have stimulated renewed interest in unenhanced techniques. Traditional unenhanced MRA techniques include phase contrast, time of fl ight, and black-blood vessel wall (double inversion recovery) imaging. All of these techniques have inferior accuracy to the newer 3D-contrast-enhanced techniques, and are therefore no longer used for clinical decision making. More recently, a new approach to unenhanced MRA has evolved using "fresh blood" imaging. With this method, electrocardiogram (ECG)-gated 3D imaging allows subtraction of diastolic images from systolic images, eliminating venous and tissue signal, without the need for contrast. It remains to be seen if "fresh blood" imaging is robust enough for clinical decision making, and what, if any, is the clinical utility of this approach. 21 Figure 3 shows an example of MRA imaging.
Multidetector computed tomography angiography
Computed tomography angiography is widely available, including after working hours. It can be used for trauma, vascular emergencies, aneurysms, and for imaging bypass grafts. It is relatively less costly, and does not require on-site sub-specialist expertise or arterial puncture. It is suitable for preoperative planning, as well as the postoperative patient when bandages and sutures (not to mention edema) might make ultrasound diffi cult or undesirable (for example because of infection risk). Unlike DU, computed tomography allows simultaneous angiographic as well as anatomical volume acquisition in seconds whilst maintaining high spatial resolution. This allows both luminal and extraluminal pathology to be shown simultaneously.
Multidetector computed tomography scanners are rapid, and imaging can be done whilst contrast is in the fi rst-pass phase of the arterial tree, so the venous contamination seen with MRA does not occur. 25 Cardiac gating improves the accuracy of thoracic aorta imaging by minimizing motion artefacts.
Computed tomography is ideal for preoperative planning of aortoiliac stent-graft placement, as well as poststent surveillance. Up to 28% of endoleaks are missed by DU (and the proportion of missed endoleaks goes up to 42% if considering type II only). 26 CTA can provide rapid and accurate imaging of en face plaque in the aortoiliac segments. 27 Similarly, computed tomography allows accurate assessment of mural thrombus in the aortoiliac region, providing the exact diameter of aneurysms, and exquisite images of the aortic wall and regional structures. 25 Three separate systematic reviews of the diagnostic accuracy of CTA for peripheral arterial disease found a pooled sensitivity and specifi city of 92% and 91% in one analysis, and 92% and 93% in the second, whereas the third reported 95% and 96% respectively (all three systematic reviews used DSA as gold-standard). [28] [29] [30] It should be noted that the fi rst two of these systematic reviews included only two papers (out of 10 and 12, respectively) with 16-detector technology; all the other results were from 4-detector technology. 28, 29 In the third systematic review, there were seven papers (out of 20) with 16-detector technology, and two papers with 64-detector technology. 30 The fi rst published results with 16-detector technology claim overall accuracy, sensitivity, and specifi city of over 96%, without any decrease in performance down to the crural branches. 31 More recent studies with 16-detector technology suggest sensitivity and specifi city of appropriately 98% for peripheral vascular disease. 32, 33 The two studies presenting data for 64-detector technology (reported in the third meta-analysis) claimed a sensitivity and specifi city for CTA of around 99% for both indicators (in the fi rst study) versus 98% and 96% respectively (in the second study). 34, 35 The current consensus position of the Joint American College of Cardiology and American Heart Association Guidelines 1 is that using CTA is controversial. This position is based on the technological lag and poor sensitivity of 4-detector scanners, and to some extent, 16-detector scanners. As the accuracy of CTA with 64-detector, 128-detector, 256-detector, and 320-detector (or more) machines emerges, the accepted consensus position on its use in the investigation of peripheral vascular disease is likely to change. It has been pointed out that the accuracy of CTA may be even higher than reported because a multi-planar 3-dimentional technology is being compared with a bi-planar (at best) or mono-planar methodology of image analysis for the gold-standard (DSA). In this case, CTA may be sensitive to disease missed by the gold-standard. 30 From 64-detector onwards, computed tomography machines have isotropic acquisition and multiplanar 3D reconstruction capabilities, with much improved scan optimization protocols. Given the speed of imaging and the number of slices acquired with multidetector technology, it is not possible to handle the images by reviewing axial slices only. Fortunately, continuous advances in imaging informatics has allowed postprocessing capability to keep up with the fi ling and transfer of the vast amount of data produced by multidetector computed tomography. Various postprocessing algorithms (including surface shaded display, volume rendering, multiplanar reconstruction, vessel density ratio, and maximum intensity projection) facilitate the radiological analysis (albeit with Imaging of peripheral vascular disease limitations, see below) and reduce the work-fl ow pressure on radiographic technicians in busy imaging departments. 25 The traditional route of access for contrast enhancement in computed tomography is venous. A study of intra-arterial contrast injection found an 88% reduction in contrast dose, 36 making the invasive approach a potentially attractive option for patients with renal impairment, especially if MRA is contraindicated, unavailable, or technically unsuccessful.
Limitations of computed tomography angiography
Computed tomography imparts a nonnegligible dose of ionizing radiation dose to patients, but with the latest technology and optimal technical factors, this radiation dose can be comparable with DSA. A typical mean effective dose for CTA study of the periphery (including lower limbs) has been reported as 12-14 mSv per study depending on technical protocol), 37,38 versus 11 mSv for DSA. 31 Computed tomography generates comprehensive anatomic volume acquisition, and this requires not only post-processing time but also formal reporting of all the voluminous imaging. Being an iodine-based contrast technique, there is a recognized associated nephrotoxicity and adverse reaction rate; and being diagnostic only, the requirement for nephrotoxic contrast needs to be considered carefully in patients who have poor renal function. In these cases, it might be necessary to preserve the little remaining nephrotoxic reserve and proceed directly to DSA with the chance of simultaneous angioplasty and defi nitive management.
Extensive vessel wall calcifi cation makes assessment of luminal stenosis very diffi cult with current computed tomography techniques. Patients with heavy calcifi cation have better diagnostic outcomes with MRA or DSA. Calcifi cation confounds the software-driven rendering and automation used in computed tomography, and images become particularly poor for the distal run-off in the presence of calcifi c disease, which is a limitation in common with DU.
Interestingly, the third meta-analysis (mentioned previously) reported that CTA overstaged 8% and understaged 15% of diseased arterial segments. 30 Overstaging can occur because of the "blooming" effect of the calcium in calcifi ed plaques, so that a patent vessel with calcifi cation is mistaken for an occluded vessel on the CT images. 39 Understaging occurs when DSA misdiagnoses patent vessels as occluded because of motion artefacts, different rates of crural vessel opacifi cation, or inadequate opacifi cation distal to an occlusion. 40 For this reason, CTA should be avoided in the elderly (Ͼ84 years), patients with renal failure, diabetes, or heart failure. 41 Similarly, in the setting of trauma, metal fragments can cause artefactual "pseudolesions", whilst vessel spasm can be diffi cult to distinguish from occlusion. 42 Metallic aneurysm clips and stents attenuate the X-ray beam, allowing too few photons to reach the X-ray detectors, and corrupting the system's ability to map the projection. Those few photons that do reach the detectors are the ones with higher energies, therefore resulting in "beam hardening". Traditional fi ltered back-projection algorithms used to reconstruct spiral computed tomography images are degraded by streaking and "star artefacts" in the plane of a metallic implant. Recent research is focusing on how to limit metallic artefacts using novel reconstruction algorithms. 43 Other limitations of computed tomography relate to the postprocessing algorithms used to facilitate analysis of the images. Maximum intensity projections can mask co-existent subtle trauma, and both maximum intensity projections and vessel density ratios exaggerate the extent of stenosis in the presence of calcifi ed plaque. In addition, multiplanar reconstruction can be poor for confi guring tortuous or off-axis arteries. 25 Figure 4 shows an example of CTA imaging.
Comparative resource implications
Studies of health care economics, quality, and outcomes are notoriously fraught with limitations. Results can vary widely, and incorporating cost adjustments for the quality of a study is far from an exact science. One group in the Netherlands recently attempted to quantify the comparative average cost and outcome based on choice of the fi rst noninvasive imaging test in patients with peripheral vascular disease. The average MRA was found to be much more expensive (at 472 Euros/study) than both CTA (163 Euros/study) and DU (104 Euros/study). Diagnostic-only digital subtraction angiograms were estimated to cost 1207 Euros/study. Being investigated with CTA as the fi rst-line study appeared to be much less costly overall (including the costs of additional tests required) than having MRA or DU as fi rst-line. However, despite these different costs, the group could not fi nd any difference between the functional or quality outcomes of patients investigated by any of the techniques as fi rst-line. 44 
Clinical algorithm for investigating peripheral vascular disease
A complementary imaging strategy would deploy the different imaging modalities to provide the most effi cient diagnostic work-up of a patient, providing complete diagnostic information to clinical decision-makers. Each imaging modality provides a different perspective of the same clinical Imaging of peripheral vascular disease problem, and could compensate for another modality's "blind spot". The imaging algorithm in Figure 5 provides a framework for the investigation of peripheral vascular disease.
Interestingly, a systematic review of the diagnostic accuracy of noninvasive imaging for detecting signifi cant arterial stenosis (head-to-head with DSA as the gold-standard) has recently been published. After data was synthesized from 58 studies, contrast-enhanced MRA came out with the highest median sensitivity (95%) and median specifi city (97%). CTA had a median sensitivity and specifi city of 91%, comparing favourably with DU (median sensitivity 88%; median specifi city 96%). 45 However, in a response to this meta-analysis, it was claimed that DSA is consistently more accurate than all the other imaging modalities at assessing less than signifi cant degrees of stenosis (ie, Ͻ50% by diameter reduction), and that this additional ability was the reason why catheter angiography was the gold-standard for triaging patients into surgical and conservative management. 46 
Conclusion
Good patient outcomes depend on prompt diagnosis, intervention whilst emergencies are reversible, and appropriate long-term management. The choice between different imaging techniques also depends on local protocols, which will refl ect the local population needs and the availability of local expertise and services. The strengths and weaknesses of the various imaging modalities also reveal how these modalities could complement each other. Table 2 summarizes the role of the various imaging modalities in the imaging of peripheral vascular disease. When investigating patients with one diagnostic modality, it is no longer possible to ignore how other modalities work. 
